Posterolateral Spine Procedures
-
Biologics
FDA Clears Bone Scaffold ReBOSSIS® for New Indication
GEORGETOWN, TEXAS (PRWEB) JANUARY 11, 2018 Last month, the Food and Drug Administration cleared ReBOSSIS®, the only biosynthetic bone scaffold with…
Read More »